Clicks Group Limited (CLCGY) Aktienanalyse
Nur zu Informationszwecken. Keine Finanzberatung. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Mit einem Kurs von $ ist Clicks Group Limited (CLCGY) ein Healthcare-Unternehmen mit einer Bewertung von 0. Bewertet mit 46/100 (vorsichtig) bei Wachstumspotenzial, finanzieller Gesundheit und Momentum.
Zuletzt analysiert: 15. März 2026Clicks Group Limited (CLCGY) Gesundheitswesen & Pipeline-Uebersicht
Clicks Group Limited is a South African health and beauty retailer and pharmaceutical distributor, operating through retail and distribution segments. With a network of approximately 840 stores and 620 in-store pharmacies, Clicks Group caters to the middle to upper-income markets, while UPD distributes pharmaceutical products to various healthcare providers.
Investmentthese
Clicks Group Limited presents a compelling investment case due to its established market position in South Africa's health and beauty retail and pharmaceutical distribution sectors. The company's diversified revenue streams, stemming from both retail and wholesale operations, provide resilience against economic fluctuations. With a P/E ratio of 21.28 and a dividend yield of 3.05%, the company offers a blend of value and income. Key growth catalysts include expansion of its retail footprint and increasing demand for pharmaceutical products. Potential risks include regulatory changes in the healthcare sector and competition from other retailers and distributors. The company's beta of 0.23 suggests relatively low volatility compared to the broader market.
Basierend auf FMP-Finanzdaten und quantitativer Analyse
Wichtige Highlights
- Market capitalization of $4.04 billion, reflecting its significant presence in the South African market.
- P/E ratio of 21.28, indicating a reasonable valuation relative to its earnings.
- Profit margin of 6.3%, demonstrating its ability to generate profits from its operations.
- Gross margin of 25.4%, reflecting the efficiency of its supply chain and pricing strategies.
- Dividend yield of 3.05%, offering an attractive income stream for investors.
Wettbewerber & Vergleichsunternehmen
Staerken
- Extensive retail network and distribution capabilities.
- Established brand reputation and customer loyalty.
- Diversified revenue streams from retail and distribution segments.
- Strong financial performance and profitability.
Schwaechen
- Concentration of operations in South Africa.
- Exposure to regulatory changes in the healthcare sector.
- Dependence on key suppliers for pharmaceutical products.
- Potential for margin pressure from competition.
Katalysatoren
- Ongoing: Expansion of retail footprint in South Africa, increasing market share.
- Ongoing: Growing demand for pharmaceutical products, boosting distribution revenue.
- Ongoing: Strategic partnerships to expand product offerings and market reach.
Risiken
- Potential: Economic downturn in South Africa, impacting consumer spending.
- Potential: Changes in government regulations and healthcare policies.
- Potential: Increased competition from other retailers and distributors.
- Ongoing: Fluctuations in currency exchange rates, affecting ADR value.
Wachstumschancen
- Expansion of Retail Footprint: Clicks Group can continue to expand its retail footprint by opening new stores in underserved areas and increasing the number of in-store pharmacies. This expansion will allow the company to reach a wider customer base and increase its market share. The South African retail market is expected to grow at a rate of 5% annually, providing a favorable environment for expansion. Timeline: Ongoing.
- Increased Demand for Pharmaceutical Products: The demand for pharmaceutical products is expected to increase due to an aging population and rising healthcare awareness. Clicks Group, through its UPD distribution segment, is well-positioned to capitalize on this trend. The South African pharmaceutical market is projected to reach $10 billion by 2028. Timeline: Ongoing.
- Growth in Specialty Health and Wellness Products: Clicks Group can further expand its offerings in specialty health and wellness products, such as vitamins, mineral supplements, and sports nutrition. This will cater to the growing demand for preventative healthcare and wellness products. The global wellness market is estimated to be worth over $1.5 trillion. Timeline: Ongoing.
- E-commerce Expansion: Clicks Group can invest in its e-commerce platform to reach customers beyond its physical store network. This will allow the company to compete with online retailers and cater to the growing demand for online shopping. The South African e-commerce market is expected to grow at a rate of 15% annually. Timeline: Ongoing.
- Strategic Partnerships and Acquisitions: Clicks Group can pursue strategic partnerships and acquisitions to expand its product offerings and market reach. This could include partnerships with other healthcare providers or acquisitions of smaller retail chains or pharmaceutical distributors. Timeline: Ongoing.
Chancen
- Expansion into new geographic markets.
- Growth in specialty health and wellness products.
- Increased demand for pharmaceutical products.
- E-commerce expansion and digital transformation.
Risiken
- Economic downturn in South Africa.
- Increased competition from other retailers and distributors.
- Changes in government regulations and healthcare policies.
- Fluctuations in currency exchange rates.
Wettbewerbsvorteile
- Extensive retail network of approximately 840 stores and 620 in-store pharmacies.
- Established brand reputation in the South African market.
- Integrated business model encompassing both retail and distribution.
- Strong relationships with pharmaceutical suppliers.
Ueber CLCGY
Founded in 1968 and headquartered in Cape Town, South Africa, Clicks Group Limited has evolved into a prominent player in the health and beauty retail and pharmaceutical distribution sectors. Initially known as New Clicks Holdings Limited, the company rebranded as Clicks Group Limited in 2009. The company operates through two primary segments: Retail and Distribution. The Retail segment focuses on pharmacy, health, and beauty products, primarily targeting the middle to upper-income markets through its Clicks-branded stores. In addition to its core Clicks stores, the company also retails specialty health and wellness products under the General Nutrition Corporation (GNC) banner, luxury toiletries and cosmetics through The Body Shop, and fashion accessories via Claire's. The Distribution segment, operating under the UPD name, is involved in the wholesale and supply of pharmaceutical products to a diverse range of customers, including retail pharmacies, private hospitals, dispensing doctors, and retail health stores. Clicks Group's extensive network comprises approximately 840 stores and 620 in-store pharmacies across South Africa.
Was das Unternehmen tut
- Operates as a health and beauty retailer in South Africa.
- Distributes pharmaceutical products to retail pharmacies, hospitals, and doctors.
- Retails pharmacy, health, and beauty products through Clicks stores.
- Sells specialty health and wellness products under the GNC brand.
- Offers luxury toiletries and cosmetics under The Body Shop brand.
- Provides fashionable jewelry and accessories through Claire's stores.
Geschaeftsmodell
- Retails health, beauty, and pharmaceutical products directly to consumers through its store network.
- Distributes pharmaceutical products wholesale to healthcare providers.
- Generates revenue through product sales in both retail and distribution segments.
- Focuses on middle to upper-income markets in South Africa.
Branchenkontext
Clicks Group Limited operates within the healthcare sector, specifically in the medical pharmaceuticals and retail pharmacy industries. The South African retail pharmacy market is characterized by increasing demand for healthcare products and services, driven by an aging population and rising healthcare awareness. The competitive landscape includes other retail chains, independent pharmacies, and pharmaceutical distributors. Clicks Group's integrated business model, encompassing both retail and distribution, provides a competitive advantage in this market. The company's extensive store network and established brand reputation further solidify its position.
Wichtige Kunden
- Individual consumers seeking health, beauty, and pharmaceutical products.
- Retail pharmacies requiring pharmaceutical supplies.
- Private hospitals needing pharmaceutical products.
- Dispensing doctors requiring pharmaceutical supplies.
Finanzdaten
Chart & Info
Clicks Group Limited (CLCGY) Aktienkurs: Price data unavailable
Aktuelle Nachrichten
Analystenkonsens
Konsens-Bewertung
Aggregierte Kauf-/Halten-/Verkauf-Empfehlungen von Benzinga, Yahoo Finance und Finnhub fuer CLCGY.
Kursziele
Wall-Street-Kurszielanalyse fuer CLCGY.
MoonshotScore
Was bedeutet diese Bewertung?
Der MoonshotScore bewertet das Wachstumspotenzial von CLCGY auf einer Skala von 0-100 ueber mehrere Faktoren wie Innovation, Marktdisruption, finanzielle Gesundheit und Momentum.
Fuehrung: Bertina D. Engelbrecht B.Proc
CEO
Bertina Engelbrecht holds a B.Proc degree and has extensive experience in the retail and healthcare sectors. She has been with Clicks Group Limited for several years, holding various leadership positions before being appointed as CEO. Her background includes expertise in strategic planning, operations management, and business development. She has a proven track record of driving growth and improving operational efficiency.
Erfolgsbilanz: Since becoming CEO, Bertina Engelbrecht has focused on expanding Clicks Group's retail footprint, enhancing its e-commerce capabilities, and strengthening its relationships with key suppliers. She has also overseen the implementation of several initiatives aimed at improving customer service and operational efficiency. Under her leadership, the company has maintained its strong financial performance and market position.
Clicks Group Limited ADR-Informationen Nicht gesponsert
An American Depositary Receipt (ADR) is a certificate representing shares of a foreign company that trades on U.S. stock exchanges. CLCGY is an ADR, meaning it allows U.S. investors to invest in Clicks Group Limited without directly dealing with foreign markets. Each CLCGY ADR represents a specific number of Clicks Group Limited's ordinary shares traded on its home market.
- Heimatmarkt-Ticker: Johannesburg Stock Exchange (JSE) in South Africa.
- ADR-Stufe: 1
- ADR-Verhaeltnis: 1:1
- Heimatmarkt-Ticker: CLCG
CLCGY OTC-Marktinformationen
The OTC Other tier represents the lowest tier of the over-the-counter (OTC) market. Companies in this tier often have limited or no financial disclosure requirements and may not meet the listing standards of major exchanges like the NYSE or NASDAQ. Investing in companies on the OTC Other tier carries higher risks due to the lack of transparency and regulatory oversight compared to exchange-listed companies. This tier is also known for having the least liquidity.
- OTC-Stufe: OTC Other
- Offenlegungsstatus: Unknown
- Limited financial disclosure and transparency.
- Lower trading volume and liquidity.
- Wider bid-ask spreads.
- Potential for price volatility.
- Increased risk of fraud or manipulation.
- Verify the company's registration and legal status.
- Investigate the company's management team and their track record.
- Assess the availability and quality of financial information.
- Review the company's business model and competitive landscape.
- Understand the risks associated with investing in OTC stocks.
- Consult with a financial advisor before investing.
- Check for any regulatory actions or legal proceedings against the company.
- Established business operations in South Africa.
- Presence of a recognized brand (Clicks).
- Availability of some company information (though disclosure level is unknown).
- ADR structure allowing U.S. investment.
CLCGY Healthcare Aktien-FAQ
What are the key factors to evaluate for CLCGY?
Clicks Group Limited (CLCGY) currently holds an AI score of 46/100, indicating low score. Key strength: Extensive retail network and distribution capabilities.. Primary risk to monitor: Potential: Economic downturn in South Africa, impacting consumer spending.. This is not financial advice.
How frequently does CLCGY data refresh on this page?
CLCGY prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven CLCGY's recent stock price performance?
Recent price movement in Clicks Group Limited (CLCGY) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Extensive retail network and distribution capabilities.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider CLCGY overvalued or undervalued right now?
Determining whether Clicks Group Limited (CLCGY) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying CLCGY?
Before investing in Clicks Group Limited (CLCGY), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Why might investors consider adding CLCGY to a portfolio?
Potential reasons to consider Clicks Group Limited (CLCGY) depend on individual investment goals and risk tolerance. A key strength identified by analysis: Extensive retail network and distribution capabilities.. Additionally: Established brand reputation and customer loyalty.. Always weigh potential rewards against risks and diversify across holdings. This is not financial advice.
Can I buy fractional shares of CLCGY?
Yes, most major brokerages offer fractional shares of Clicks Group Limited (CLCGY) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.
How can I track CLCGY's earnings and financial reports?
Clicks Group Limited (CLCGY) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Setting up alerts through your brokerage for CLCGY earnings announcements is recommended.
Haftungsausschluss: Dieser Inhalt dient ausschliesslich zu Informationszwecken und stellt keine Anlageberatung dar. Fuehren Sie immer Ihre eigene Recherche durch und konsultieren Sie einen Finanzberater.
Offizielle Ressourcen
Daten dienen ausschliesslich zu Informationszwecken.
- Limited analyst coverage due to OTC listing.
- Disclosure status on OTC market is unknown.